Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Sachdev Amit
Relationship:  
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   71,325    

Indirect Shares

   7,447      
Direct Value   $24,511,741    

Indirect Value

   $3,299,393      
Total Shares   78,772      
Total Value   $27,811,135      


Vertex Pharmaceuticals Inc $24,511,741 Celladon Corp $0 Vertex Pharmaceuticals Inc $24,511,741 Celladon Corp $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Vertex Pharmaceuticals Inc VRTX EVP Chief Patient & Ex... 2024-05-15 55,325 2024-05-15 7,447    Premium*  
            Celladon Corp CLDN 2022-03-11 16,000 2020-03-12 0    Premium*  
* Premium Members only  

Records found :    193         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
VRTX Vertex Pharmaceuticals In... EVP Chief Patient & Ext Af Off   •       –      –    2024-02-20 4 D $420.58 $1,103,181 D/D (2,623) 68,243 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2021-02-24 4 D $217.57 $640,961 D/D (2,946) 43,719 0 -
VRTX Vertex Pharmaceuticals In... EVP Chief Patient & Ext Af Off   •       –      –    2024-02-26 4 AS $425.70 $1,278,803 D/D (3,004) 55,325 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-02-24 4 D $239.23 $755,010 D/D (3,156) 36,291 0 -
VRTX Vertex Pharmaceuticals In... EVP Chief Patient & Ext Af Off   •       –      –    2024-02-21 4 AS $421.77 $1,345,868 D/D (3,191) 60,798 0 %
VRTX Vertex Pharmaceuticals In... EVP Chief Patient & Ext Af Off   •       –      –    2024-02-12 4 AS $420.24 $1,354,013 D/D (3,222) 74,364 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-02-17 4 D $241.50 $787,773 D/D (3,262) 42,936 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-02-25 4 AS $230.00 $788,402 D/D (3,376) 32,915 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-12-08 4 GD $0.00 $0 I/I 3,391 7,368 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-02-18 4 AS $242.04 $849,780 D/D (3,489) 39,447 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2022-02-17 4 D $232.51 $813,087 D/D (3,497) 55,578 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2023-02-17 4 D $292.85 $1,024,389 D/D (3,498) 68,986 0 -
VRTX Vertex Pharmaceuticals In... EVP Chief Patient & Ext Af Off   •       –      –    2024-02-16 4 D $424.01 $1,483,187 D/D (3,498) 70,866 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2021-02-25 4 AS $211.56 $765,307 D/D (3,586) 40,133 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2019-10-22 4 OE $86.52 $335,957 D/D 3,883 37,299 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2019-10-22 4 AS $190.27 $738,818 D/D (3,883) 33,416 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2021-04-27 4 OE $86.52 $336,044 D/D 3,884 44,017 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2021-04-27 4 AS $215.58 $839,193 D/D (3,884) 40,133 0 %
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2012-01-19 4 AS $37.00 $150,442 D/D (4,066) 35,008 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2018-06-29 4 AS $165.00 $686,615 D/D (4,096) 46,662 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2018-06-29 4 OE $86.52 $364,148 D/D 4,096 50,758 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2019-02-04 4 OE $86.52 $364,235 D/D 4,097 48,817 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2019-11-04 4 OE $86.52 $364,235 D/D 4,097 37,513 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2019-11-04 4 AS $199.77 $820,795 D/D (4,097) 33,416 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-02-03 4 OE $86.52 $364,239 D/D 4,097 40,287 0 -
  193  Records found
  1   2   3  4   5   6   7   8      
  Page 3 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us